JP2015506941A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015506941A5 JP2015506941A5 JP2014552484A JP2014552484A JP2015506941A5 JP 2015506941 A5 JP2015506941 A5 JP 2015506941A5 JP 2014552484 A JP2014552484 A JP 2014552484A JP 2014552484 A JP2014552484 A JP 2014552484A JP 2015506941 A5 JP2015506941 A5 JP 2015506941A5
- Authority
- JP
- Japan
- Prior art keywords
- methyltetrahydrofolate
- crystalline form
- angle
- ray diffraction
- diffraction pattern
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002441 X-ray diffraction Methods 0.000 claims 2
- 239000011578 levomefolic acid Substances 0.000 claims 2
- ZNOVTXRBGFNYRX-ABLWVSNPSA-N levomefolic acid Chemical compound C1NC=2NC(N)=NC(=O)C=2N(C)C1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 ZNOVTXRBGFNYRX-ABLWVSNPSA-N 0.000 claims 2
- 235000007635 levomefolic acid Nutrition 0.000 claims 2
- JMNIIIQOMSQWJN-ZEXVLMPOSA-L calcium;(2s)-2-[[4-[[(6s)-2-amino-5-methyl-4-oxo-1,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]-5-hydroxy-5-oxopentanoate Chemical compound [Ca+2].C([C@@H]1N(C=2C(=O)NC(N)=NC=2NC1)C)NC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C(O)=O)C=C1.C([C@@H]1N(C=2C(=O)NC(N)=NC=2NC1)C)NC1=CC=C(C(=O)N[C@@H](CCC([O-])=O)C(O)=O)C=C1 JMNIIIQOMSQWJN-ZEXVLMPOSA-L 0.000 claims 1
- KJUCVIHHEMCARO-ZEXVLMPOSA-L strontium (4S)-4-[[4-[[(6S)-2-amino-5-methyl-4-oxo-3,6,7,8-tetrahydropteridin-6-yl]methylamino]benzoyl]amino]-5-hydroxy-5-oxopentanoate Chemical compound [Sr+2].CN1C=2C(NC(=NC2NC[C@@H]1CNC1=CC=C(C(N[C@@H](CCC(=O)[O-])C(=O)O)=O)C=C1)N)=O.CN1C=2C(NC(=NC2NC[C@@H]1CNC1=CC=C(C(N[C@@H](CCC(=O)[O-])C(=O)O)=O)C=C1)N)=O KJUCVIHHEMCARO-ZEXVLMPOSA-L 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210018941.9A CN102775407B (zh) | 2012-01-20 | 2012-01-20 | 稳定的无定型5-甲基四氢叶酸盐及其制备方法 |
| CN201210018941.9 | 2012-01-20 | ||
| CN201210019038.4 | 2012-01-20 | ||
| CN201210019038.4A CN102584826B (zh) | 2012-01-20 | 2012-01-20 | (6s)-5-甲基四氢叶酸盐晶型及其制备方法 |
| CN201210125133.2 | 2012-04-25 | ||
| CN201210125133.2A CN102702200B (zh) | 2012-04-25 | 2012-04-25 | (6rs)-5-甲基四氢叶酸钙盐晶型及其制备方法 |
| PCT/CN2012/086794 WO2013107236A1 (zh) | 2012-01-20 | 2012-12-17 | （6s）-5-甲基四氢叶酸盐晶型及其制备方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015506941A JP2015506941A (ja) | 2015-03-05 |
| JP2015506941A5 true JP2015506941A5 (OSRAM) | 2015-11-26 |
| JP6166736B2 JP6166736B2 (ja) | 2017-07-19 |
Family
ID=48798580
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014552484A Active JP6166736B2 (ja) | 2012-01-20 | 2012-12-17 | （６ｓ）−５−メチルテトラヒドロ葉酸塩の結晶形及びそれを製造する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9150982B2 (OSRAM) |
| EP (1) | EP2805952B1 (OSRAM) |
| JP (1) | JP6166736B2 (OSRAM) |
| KR (1) | KR101694710B1 (OSRAM) |
| BR (1) | BR112014017939A2 (OSRAM) |
| CA (1) | CA2861891C (OSRAM) |
| ES (1) | ES2715599T3 (OSRAM) |
| HR (1) | HRP20190317T1 (OSRAM) |
| IN (1) | IN2014DN06942A (OSRAM) |
| PL (1) | PL2805952T3 (OSRAM) |
| WO (1) | WO2013107236A1 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015193778A1 (en) | 2014-06-16 | 2015-12-23 | Mylan Laboratories Ltd. | Crystalline form of levomefolate calcium |
| EP3190112A4 (en) | 2014-09-04 | 2017-09-13 | Lianyungang Jinkang Hexin Pharmaceutical Co., Ltd. | Composition of (6s)-5-methyl tetrahydrofolic acid or salt thereof as well as preparation therefor and application thereof |
| JP7285785B2 (ja) | 2017-03-31 | 2023-06-02 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | ５－メチル－（６ｓ）－テトラヒドロ葉酸の結晶性ナトリウム塩 |
| CN110461845B (zh) * | 2017-03-31 | 2023-05-12 | 默克专利股份有限公司 | 5-甲基-（6s）-四氢叶酸的结晶钠盐 |
| FI3817814T3 (fi) * | 2018-07-06 | 2023-12-13 | Merck Patent Gmbh | 5-metyyli-(6S)-tetrahydrofoolihapon ja L-valiinietyyliesterin kiteisiä suoloja |
| BR112022002123A2 (pt) * | 2019-08-06 | 2022-04-12 | Lianyungang Jinkang Hexin Pharmaceutical Co Ltd | Composição farmacêutica para produzir uma quantidade segura de óxido nítrico e seu uso |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223500A (en) | 1977-02-22 | 1993-06-29 | Bioresearch S.P.A. | Stable pharmaceutical composition of alkaline or alkaline earth 5-methyl tetrahydrofolate |
| US5471001A (en) * | 1994-12-15 | 1995-11-28 | E. I. Du Pont De Nemours And Company | Crystallization of adipic acid |
| CH693905A5 (de) | 1999-04-15 | 2004-04-15 | Eprova Ag | Stabile kristalline Salze von 5-Methyltetrahydrofolsäure. |
| DE10137017A1 (de) * | 2001-07-30 | 2003-02-20 | Basf Ag | Kristallisationsverfahren zur Einstellung kleiner Partikel |
| US20090298884A1 (en) * | 2005-05-06 | 2009-12-03 | Glenmark Generics Ltd. | Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same |
| CN100336814C (zh) * | 2005-11-23 | 2007-09-12 | 天津大学 | 溶剂超声协同作用制备球状结晶核黄素方法 |
| KR100878140B1 (ko) * | 2007-01-29 | 2009-01-12 | 한미약품 주식회사 | 아토바스타틴의 스트론튬염 또는 이의 수화물, 및 이를포함하는 약학 조성물 |
| CH698729B1 (de) | 2007-05-30 | 2009-10-15 | Cerbios Pharma Sa | Stabile, kristalline (6S)-N(5)-Methyl-5, 6,7,8-tetrahydrofolsäure. |
| CN102702200B (zh) * | 2012-04-25 | 2014-11-12 | 连云港金康和信药业有限公司 | (6rs)-5-甲基四氢叶酸钙盐晶型及其制备方法 |
| CN102775407B (zh) * | 2012-01-20 | 2015-08-05 | 连云港金康医药科技有限公司 | 稳定的无定型5-甲基四氢叶酸盐及其制备方法 |
| CN102584826B (zh) * | 2012-01-20 | 2015-04-29 | 连云港金康医药科技有限公司 | (6s)-5-甲基四氢叶酸盐晶型及其制备方法 |
-
2012
- 2012-12-17 HR HRP20190317TT patent/HRP20190317T1/hr unknown
- 2012-12-17 JP JP2014552484A patent/JP6166736B2/ja active Active
- 2012-12-17 CA CA2861891A patent/CA2861891C/en active Active
- 2012-12-17 PL PL12865798T patent/PL2805952T3/pl unknown
- 2012-12-17 KR KR1020147023261A patent/KR101694710B1/ko active Active
- 2012-12-17 ES ES12865798T patent/ES2715599T3/es active Active
- 2012-12-17 EP EP12865798.8A patent/EP2805952B1/en active Active
- 2012-12-17 IN IN6942DEN2014 patent/IN2014DN06942A/en unknown
- 2012-12-17 BR BR112014017939-5A patent/BR112014017939A2/pt not_active Application Discontinuation
- 2012-12-17 US US14/373,262 patent/US9150982B2/en active Active
- 2012-12-17 WO PCT/CN2012/086794 patent/WO2013107236A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016146119A (ru) | Новый кристалл тетрациклического соединения | |
| JP2018024682A5 (OSRAM) | ||
| JP2015506941A5 (OSRAM) | ||
| JP2019510768A5 (OSRAM) | ||
| JP2013173781A5 (OSRAM) | ||
| IL242278A0 (en) | Compounds 4)-n-fluoro-2-methoxy-5-nitrophenyl)pyrimidine-2-converted amine and their salts | |
| HUE036287T2 (hu) | Vegyület új kalciumsói gyulladásellenes, immunmoduláns és antiproliferatív szerekként | |
| JP2011520976A5 (OSRAM) | ||
| JP2016504351A5 (OSRAM) | ||
| JP2012036197A5 (OSRAM) | ||
| JP2014515954A5 (OSRAM) | ||
| IL224450B (en) | Crystalline forms of pyrimido[6,1-a] isoquinolin-4-one compounds | |
| JP2012090279A5 (OSRAM) | ||
| JP2012531408A5 (OSRAM) | ||
| HK1213895A1 (zh) | 可作為激酶調節劑的經雜芳基取代的呲啶基化合物 | |
| JP2013521273A5 (OSRAM) | ||
| JP2019508220A5 (OSRAM) | ||
| IL245585B (en) | Crystalline form of the hcl salt of a compound for suppressing the reproduction of influenza viruses and methods of production of the crystalline form thereof | |
| AR082804A1 (es) | Formas cristalinas de un inhibidor del factor xa | |
| JP2013507408A5 (OSRAM) | ||
| JP2012502876A5 (OSRAM) | ||
| JP2013500200A5 (OSRAM) | ||
| JP2016000739A5 (OSRAM) | ||
| WO2015017378A3 (en) | Novel copper-cysteamine and methods of use | |
| MX2015013020A (es) | Polimorfos de sovaprevir y metodos de fabricacion de los mismos. |